An underground economy for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Drug Acquiring Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these accounts directly for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Voice Worries
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering products of uncertain source.
Several experts said the demand for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, risking fines, legal action or prison.
Platform Response and Material Elimination
According to the social media company, the platform has removed problematic material and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of weight loss, positive reviews and step-by-step guides for preparing or administering at home.
After moments of joining one group, a seller posted contact information, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or past usage.
Item Information and Pricing
Inside these groups, posts display dark colored packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for Telegram stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her staff has already seen individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to possibly serious medical dangers”.
